-
1
-
-
67650380136
-
Biomarkers of response and resistance to antiangiogenic therapy
-
Jain RK, Duda DG, Willett CG, et al. Biomarkers of response and resistance to antiangiogenic therapy. Nat Rev Clin Oncol. 2009, 6(6): 327-338.
-
(2009)
Nat Rev Clin Oncol
, vol.6
, Issue.6
, pp. 327-338
-
-
Jain, R.K.1
Duda, D.G.2
Willett, C.G.3
-
2
-
-
75549085009
-
Circulating tumor-derived predictive biomarkers in oncology
-
Hodgson DR, Wellings E, Orr M, et al. Circulating tumor-derived predictive biomarkers in oncology. Drug Discov Today. 2010, 15(3-4): 98-101.
-
(2010)
Drug Discov Today
, vol.15
, Issue.3-4
, pp. 98-101
-
-
Hodgson, D.R.1
Wellings, E.2
Orr, M.3
-
3
-
-
78149472680
-
Optimizing the management of HER2-positive early breast cancer: the clinical reality
-
Verma S, Lavasani S, Mackey J, et al. Optimizing the management of HER2-positive early breast cancer: the clinical reality. Curr Oncol. 2010, 17(4): 20-33.
-
(2010)
Curr Oncol
, vol.17
, Issue.4
, pp. 20-33
-
-
Verma, S.1
Lavasani, S.2
Mackey, J.3
-
4
-
-
36849069347
-
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
-
Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007, 25(33): 5287-5312.
-
(2007)
J Clin Oncol
, vol.25
, Issue.33
, pp. 5287-5312
-
-
Harris, L.1
Fritsche, H.2
Mennel, R.3
-
5
-
-
78649825336
-
Current and emerging biomarkers in breast cancer: prognosis and prediction [published online ahead of print July 10 2010]
-
Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction [published online ahead of print July 10, 2010]. Endocr Relat Cancer. 2010, 17(4): 245-262.
-
(2010)
Endocr Relat Cancer
, vol.17
, Issue.4
, pp. 245-262
-
-
Weigel, M.T.1
Dowsett, M.2
-
6
-
-
77955715822
-
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer
-
Colleoni M, Bagnardi V, Rotmensz N, et al. A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer. Eur J Cancer. 2010, 46(12): 2216-2224.
-
(2010)
Eur J Cancer
, vol.46
, Issue.12
, pp. 2216-2224
-
-
Colleoni, M.1
Bagnardi, V.2
Rotmensz, N.3
-
7
-
-
33748693297
-
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
-
Buyse M, Loi S, van't Veer L, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst. 2006, 98(17): 1183-1192.
-
(2006)
J Natl Cancer Inst
, vol.98
, Issue.17
, pp. 1183-1192
-
-
Buyse, M.1
Loi, S.2
van't Veer, L.3
-
8
-
-
34250652449
-
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
-
Desmedt C, Piette F, Loi S, et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res. 2007, 13(11): 3207-3214.
-
(2007)
Clin Cancer Res
, vol.13
, Issue.11
, pp. 3207-3214
-
-
Desmedt, C.1
Piette, F.2
Loi, S.3
-
9
-
-
55749109051
-
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
-
Nolen BM, Marks JR, Ta'san S, et al. Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. Breast Cancer Res. 2008, 10(3): R45.
-
(2008)
Breast Cancer Res
, vol.10
, Issue.3
-
-
Nolen, B.M.1
Marks, J.R.2
Ta'san, S.3
-
10
-
-
4143094988
-
Circulating tumor cells, disease progression and survival in metastatic breast cancer
-
Cristofanilli M, Budd T, Ellis MJ, et al. Circulating tumor cells, disease progression and survival in metastatic breast cancer. N Engl J Med. 2004, 351(8): 781-791.
-
(2004)
N Engl J Med
, vol.351
, Issue.8
, pp. 781-791
-
-
Cristofanilli, M.1
Budd, T.2
Ellis, M.J.3
-
11
-
-
76749130731
-
Circulating tumor cells as a prognostic marker in metastatic breast cancer
-
Andreopoulou E, Cristofanilli M. Circulating tumor cells as a prognostic marker in metastatic breast cancer. Expert Rev Anticancer Ther. 2010, 10(2): 171-177.
-
(2010)
Expert Rev Anticancer Ther
, vol.10
, Issue.2
, pp. 171-177
-
-
Andreopoulou, E.1
Cristofanilli, M.2
-
12
-
-
77649237594
-
Circulating tumor cells in clinical practice: methods of detection and possible characterization
-
Alunni-Fabbroni M, Sandri MT. Circulating tumor cells in clinical practice: methods of detection and possible characterization. Methods. 2010, 50(4): 289-297.
-
(2010)
Methods
, vol.50
, Issue.4
, pp. 289-297
-
-
Alunni-Fabbroni, M.1
Sandri, M.T.2
-
13
-
-
58549113573
-
Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells
-
Sieuwerts AM, Kraan J, Bolt J, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst. 2009, 101(1): 61-66.
-
(2009)
J Natl Cancer Inst
, vol.101
, Issue.1
, pp. 61-66
-
-
Sieuwerts, A.M.1
Kraan, J.2
Bolt, J.3
-
14
-
-
79954689654
-
Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146 [published online ahead of print April 9 2010]
-
Mostert B, Kraan J, Bolt-de Vries J, et al. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146 [published online ahead of print April 9, 2010]. Breast Cancer Res Treat. 2011, 127(1): 33-41.
-
(2011)
Breast Cancer Res Treat
, vol.127
, Issue.1
, pp. 33-41
-
-
Mostert, B.1
Kraan, J.2
Bolt-de Vries, J.3
-
15
-
-
78649613643
-
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
-
Obermayr E, Sanchex-Cabo F, Tea MK, et al. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC Cancer. 2010, 3(10): 666.
-
(2010)
BMC Cancer
, vol.3
, Issue.10
, pp. 666
-
-
Obermayr, E.1
Sanchex-Cabo, F.2
Tea, M.K.3
-
16
-
-
70249150745
-
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer
-
De Giorgi U, Valero V, Rohren E, et al. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol. 2009, 27(20): 3303-3311.
-
(2009)
J Clin Oncol
, vol.27
, Issue.20
, pp. 3303-3311
-
-
De Giorgi, U.1
Valero, V.2
Rohren, E.3
-
17
-
-
57049162148
-
Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial
-
Pierga JY, Bidard FC, Mathior C, et al. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res. 2008, 14(21): 7004-7010.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.21
, pp. 7004-7010
-
-
Pierga, J.Y.1
Bidard, F.C.2
Mathior, C.3
-
18
-
-
77953007231
-
Circulating tumor cells in the management of breast cancer
-
Nagaiah G, Abraham J. Circulating tumor cells in the management of breast cancer. Clin Breast Cancer. 2010, 10(3): 209-216.
-
(2010)
Clin Breast Cancer
, vol.10
, Issue.3
, pp. 209-216
-
-
Nagaiah, G.1
Abraham, J.2
-
19
-
-
55549115023
-
Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
-
Dawood S, Broglio K, Valero V, et al. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer. 2008, 113(9): 2422-2430.
-
(2008)
Cancer
, vol.113
, Issue.9
, pp. 2422-2430
-
-
Dawood, S.1
Broglio, K.2
Valero, V.3
-
20
-
-
77956132705
-
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy [published online ahead of print March 16 2010]
-
Bidard FC, Mathiot C, Degeorges A, et al. Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy [published online ahead of print March 16, 2010]. Ann Oncol. 2010, 21(9): 1765-1771.
-
(2010)
Ann Oncol
, vol.21
, Issue.9
, pp. 1765-1771
-
-
Bidard, F.C.1
Mathiot, C.2
Degeorges, A.3
-
21
-
-
0034082024
-
Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer
-
Sorenson GD. Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Clin Cancer Res. 2000, 6(6): 2129-2137.
-
(2000)
Clin Cancer Res
, vol.6
, Issue.6
, pp. 2129-2137
-
-
Sorenson, G.D.1
-
22
-
-
77449135297
-
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
-
Schwarzenbach H, Pantel K, Kemper B, et al. Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer. Breast Cancer Res. 2009, 11(5): R71.
-
(2009)
Breast Cancer Res
, vol.11
, Issue.5
-
-
Schwarzenbach, H.1
Pantel, K.2
Kemper, B.3
-
23
-
-
77958557955
-
Molecular biomarker analyses using circulating tumor cells
-
Punnoose EA, Atwal SK, Spoerke JM, et al. Molecular biomarker analyses using circulating tumor cells. PLoS One. 2010, 5(9): e12517.
-
(2010)
PLoS One
, vol.5
, Issue.9
-
-
Punnoose, E.A.1
Atwal, S.K.2
Spoerke, J.M.3
-
24
-
-
77952120469
-
Improving the yield of circulating tumour cells facilitates molecular characterization and recognition of discordant HER2 amplification in breast cancer
-
Flores LM, Kindelberger DW, Ligon AH, et al. Improving the yield of circulating tumour cells facilitates molecular characterization and recognition of discordant HER2 amplification in breast cancer. Br J Cancer. 2010, 102(10): 1495-1502.
-
(2010)
Br J Cancer
, vol.102
, Issue.10
, pp. 1495-1502
-
-
Flores, L.M.1
Kindelberger, D.W.2
Ligon, A.H.3
-
25
-
-
77958486873
-
Circulating tumor cells and emerging blood biomarkers in breast cancer [published online ahead of print August 11 2010]
-
Criscitiello C, Sotirou C, Ignatiadis M. Circulating tumor cells and emerging blood biomarkers in breast cancer [published online ahead of print August 11, 2010]. Curr Opin Oncol. 2010, 22(6): 552-558.
-
(2010)
Curr Opin Oncol
, vol.22
, Issue.6
, pp. 552-558
-
-
Criscitiello, C.1
Sotirou, C.2
Ignatiadis, M.3
|